ciprofloxacin has been researched along with kojic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abedi, D; Bostaki, G; Deilami, O; Fassihi, A; Fazeli, H; Sabet, R; Sadinpour, H; Saghaie, L | 1 |
| Fu, Y; Li, C; Li, S; Liu, Y; Yang, Y; Yuan, Y; Zhou, S | 1 |
2 other study(ies) available for ciprofloxacin and kojic acid
| Article | Year |
|---|---|
Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Candida albicans; Microbial Sensitivity Tests; Pyridones; Pyrones; Quantitative Structure-Activity Relationship; Staphylococcus aureus | 2009 |
Ciprofloxacin containing Mannich base and its copper complex induce antitumor activity via different mechanism of action.
Topics: Apoptosis; Cell Cycle; Cell Proliferation; Ciprofloxacin; Copper; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Mannich Bases; Neoplasms; Pyrones | 2014 |